This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mancilla, J Articles by Dinarello, C A Search for Related Content PubMed PubMed Citation Articles by Mancilla, J Articles by Dinarello, C A

The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

ABSTRACT

Klebsiella pneumoniae, a worldwide cause of nosocomial infections, is one of the most common causes of death in newborns in nurseries. In this study, we investigated the role of interleukin-1 (IL-1) in an experimental animal model of neonatal sepsis, using a natural antagonist of IL-1 receptors, the IL-1 receptor antagonist (IL-1Ra), to block IL-1's effects in neonatal Klebsiella sepsis in the absence of antibiotic treatment. Newborn Wistar-Kyoto rats were injected intraperitoneally with a single dose (10 mg/kg) of either IL-1Ra (n = 43) or human serum albumin as a control (n = 40). At the same time, a 50% lethal dose of K. pneumoniae was injected subcutaneously. No antibiotics were given at any time. After 10 days, survival was 60% for the albumin group and 80% for the IL-1Ra group (P < 0.01). IL-1Ra treatment also afforded protection when the dose of bacteria was increased sixfold (P < 0.01). There were two episodes of leukopenia in the control group, which were suppressed by IL-1Ra (P < 0.01 and P < 0.001). IL-1 and IL-6 levels were lower in the IL-1Ra-treated group (P < 0.05 and P < 0.001, respectively). No differences between the two groups were observed in the number of bacteria in cultures of the blood, lungs, liver, or spleen. When IL-1Ra (10 mg/kg) was given both at time zero and 24 h after bacterial challenge, lethality was significantly increased (P < 0.01). Single doses of IL-1Ra of from 20 to 40 mg/kg progressively increased lethality compared with controls (P < 0.01) in both Wistar-Kyoto and Sprague-Dawley strain rats. In the same model, low doses of IL-1 itself (0.4 ng per rat), given 24 h prior to bacterial challenge, afforded protection (P < 0.001). These studies suggest that, in the absence of antibiotics, partial blockade of IL-1 receptors improves survival, whereas a longer or greater blockade increases lethality in newborn rats infected with K. pneumoniae.

This article has been cited by other articles:

• Peter, J. V., John, P., Graham, P. L, Moran, J. L, George, I. A., Bersten, A. (2008). Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 336: 1006-1009 [Abstract] [Full Text]  
• Joshi, V. D., Kalvakolanu, D. V., Hebel, J. R., Hasday, J. D., Cross, A. S. (2002). Role of Caspase 1 in Murine Antibacterial Host Defenses and Lethal Endotoxemia. Infect. Immun. 70: 6896-6903 [Abstract] [Full Text]  
• Wang, L., Das, H., Kamath, A., Li, L., Bukowski, J. F. (2002). Human V{gamma}2V{delta}2 T Cells Augment Migration-Inhibitory Factor Secretion and Counteract the Inhibitory Effect of Glucocorticoids on IL-1{beta} and TNF-{alpha} Production. J. Immunol. 168: 4889-4896 [Abstract] [Full Text]  
• Calkins, C. M., Bensard, D. D., Shames, B. D., Pulido, E. J., Abraham, E., Fernandez, N., Xianzhong Meng, , Dinarello, C. A., McIntyre, R. C. JR (2002). IL-1 regulates in vivo C--X--C chemokine induction and neutrophil sequestration following endotoxemia. Innate Immunity 8: 59-67 [Abstract]  
• Boelens, J. J., van der Poll, T., Zaat, S. A. J., Murk, J. L. A. N., Weening, J. J., Dankert, J. (2000). Interleukin-1 Receptor Type I Gene-Deficient Mice Are Less Susceptible to Staphylococcus epidermidis Biomaterial-Associated Infection than Are Wild-Type Mice. Infect. Immun. 68: 6924-6931 [Abstract] [Full Text]  
• Zantl, N., Uebe, A., Neumann, B., Wagner, H., Siewert, J.-R., Holzmann, B., Heidecke, C.-D., Pfeffer, K. (1998). Essential Role of Gamma Interferon in Survival of Colon Ascendens Stent Peritonitis, a Novel Murine Model of Abdominal Sepsis. Infect. Immun. 66: 2300-2309 [Abstract] [Full Text]  
• Dinarello, C.A. (1995). Blocking interleukin-1 in sepsis. Innate Immunity 2: 157-162 [Abstract]